Items where authors include "Saumtally, H."

Article

Caley, L.R. orcid.org/0000-0001-8957-1018, Gillgrass, L., Zagoya, C. et al. (5 more authors) (2025) Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. Journal of Cystic Fibrosis, 24 (4). pp. 787-791. ISSN 1569-1993

Conference or Workshop Item

Eng, C., Saumtally, H. orcid.org/0009-0001-8967-2991, Sawant, A. et al. (4 more authors) (2025) Clinical manifestations of Post-Transplant Lymphoproliferative Disorder in Cystic Fibrosis: Experience from a regional adult CF centre. In: 2025 ERS Congress, 27 Sep - 01 Oct 2025, Amsterdam, Netherlands.

Smyth, A., Stewart, I., Sills, D. et al. (12 more authors) (2025) 592 Gut research advancing a mechanistic & personalised understanding of symptoms in CF (GRAMPUS-CF): clinical manifestations. In: 2025 North American Cystic Fibrosis Conference, 22-25 Oct 2025, Seattle, Washington.

Calthorpe, R.J., Saumtally, H., Howells, L. et al. (13 more authors) (2025) EPS4.05CF Tummy Tracker: development of a cystic fibrosis-specific patient reported outcome measure for daily gastrointestinal symptom burden. In: 48th European Cystic Fibrosis Conference, 04-07 Jun 2025, Milan, Italy.

Moull, A., Shimmin, D., Saumtally, H. orcid.org/0009-0001-8967-2991 et al. (6 more authors) (2025) P356 Patient satisfaction and experience of a liquid soluble fibre supplement for reported gastro-intestinal (GI) symptoms in a regional adult CF service: results from an online survey. In: 48th European Cystic Fibrosis Conference – 2025, 04-07 Jun 2025, Milan, Italy.

Calthorpe, R.J., Saumtally, H., Howells, L.M. et al. (13 more authors) (2024) P278 CF Tummy Tracker: ACF-specific patient reported outcome measure for daily gastrointestinal symptom burden. In: 47th European Cystic Fibrosis Conference, 05-08 Jun 2024, Glasgow, UK.

Proceedings Paper

Gillgrass, L., Caley, L. orcid.org/0000-0001-8957-1018, Zagoya, C. et al. (5 more authors) (2024) P318 Abdominal symptoms after longer term use of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 47th European Cystic Fibrosis Conference, 05 Jun 2024 - 08 Jun 2025, Glasgow, UK. Elsevier .